Federica Draghi

About

Federica is Managing Partner of XGEN Venture and currently serves on the boards of EpilepsyGTx, Protembis, Aavantgarde and InnovHeart. She co-founded XGEN in 2021 leveraging extensive expertise in life sciences and venture capital. Before XGEN, Federica was Investment Director at Genextra from 2006, where she continues to contribute as a board member and co-investor in its portfolio companies. Her previous roles include board positions at Erydel and Kuste Biopharma, as well as operational roles such as COO of Congenia. Federica began her career in academia as a postdoctoral fellow at the Medical Research Council (MRC) in Cambridge, UK, focusing on the structural biology of mitochondrial proteins. She is actively involved in the life sciences community as a co-founder of Italian Angels for Biotech (IAB) and a former board member of Assobiotec. Federica holds an MBA from Columbia University, a PhD specializing in protein crystallography, and a master’s degree in biochemistry (summa cum l

Source (opens in a new tab)